HeraMED Limited (ASX:HMD)
Australia · Delayed Price · Currency is AUD 0.0410
+0.0020 (5.13%)
Sep 17, 2026, 4:10 PM AEST
HeraMED Market Cap
HeraMED has a market cap or net worth of 47.5 million as of September 17, 2026. Its market cap has increased by 26.75% in one year.
Market Cap
47.50M
Enterprise Value
44.58M
Revenue
330.44K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
ChartMarket Cap Chart
Since December 12, 2018, HeraMED's market cap has increased from 15.76M to 47.50M, an increase of 201.51%. That is a compound annual growth rate of 15.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 47.50M | 23.30% |
| Dec 31, 2025 | 38.53M | 120.00% |
| Dec 31, 2024 | 17.51M | 127.12% |
| Dec 29, 2023 | 7.71M | -74.58% |
| Dec 30, 2022 | 30.33M | -32.86% |
| Dec 31, 2021 | 45.18M | 173.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SomnoMed | 73.62M |
| Cyclopharm | 67.90M |
| Epiminder | 60.67M |
| Compumedics | 54.93M |
| Cleo Diagnostics | 42.50M |
| Nova Eye Medical | 37.03M |
| OncoSil Medical | 35.41M |
| Control Bionics | 33.13M |